Clinical Trial Update: Low Dose Cyclophosphamide +/-- Nintedanib in Advanced Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating low dose cyclophosphamide with or without nintedanib in advanced ovarian cancer and fallopian tube cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Nintedanib (nintedanib)

Snippet

Sponsor: University College, London | Conditions: Ovarian Cancer, Fallopian Tube Cancer | Phase 2 | Status: COMPLETED